Moderna shares get a shot in the arm after cancer vaccine results

Moderna shares soared more than 172% after strong results for its vaccine for melanoma skin cancer. Elsewhere, the Evergrande saga came to a dramatic conclusion in a Shenzhen court. And what will Walmart spend its $3 billion Trump tariffs rebate on? World Business Express - Finance, economy and business news from BBC journalists around the world. The stories that matter: World Business Express…